Literature DB >> 16873565

"Occult" mastocytosis with activating c-kit point mutation evolving into systemic mastocytosis associated with plasma cell myeloma and secondary amyloidosis.

K Sotlar1, W Saeger, F Stellmacher, J Stahmer, S Jäckle, P Valent, H-P Horny.   

Abstract

A case of a 70-year-old man presenting with exsudative enteropathy due to light-chain-associated amyloidosis is reported. The diagnosis of systemic mastocytosis associated with IgG/lambda plasma cell myeloma and secondary generalised amyloidosis was carried out by morphological evaluation of bone marrow biopsy. The c-kit point mutation D816Y was detected by molecular analysis. Two years before, a cystadenolymphoma of the left parotid gland had been removed. A moderate increase of loosely scattered spindle-shaped mast cells, a subpopulation of them expressing CD25, an antigen that is not expressed by normal or reactive mast cells, was shown by retrospective analysis carried out on an intraparotideal lymph node. The c-kit mutation D816Y was shown by the molecular analysis of the lymph node. In summary, the notion that systemic mastocytosis may very rarely be associated with B cell neoplasms and that neoplastic mast cell infiltrates may be obscured because of only a minimal increase of atypical mast cells, which are outnumbered by other non-neoplastic cells in the same tissue, is supported by this case. This finding was preliminarily termed "occult" mastocytosis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16873565      PMCID: PMC1860446          DOI: 10.1136/jcp.2005.028837

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  19 in total

1.  One-step detection of c-kit point mutations using peptide nucleic acid-mediated polymerase chain reaction clamping and hybridization probes.

Authors:  Karl Sotlar; Luis Escribano; Olfert Landt; Stefanie Möhrle; Sonia Herrero; Antonio Torrelo; Ulrich Lass; Hans-Peter Horny; Burkhard Bültmann
Journal:  Am J Pathol       Date:  2003-03       Impact factor: 4.307

Review 2.  Spectrum of associated clonal hematologic non-mast cell lineage disorders occurring in patients with systemic mastocytosis.

Authors:  Wolfgang R Sperr; Hans-Peter Horny; Peter Valent
Journal:  Int Arch Allergy Immunol       Date:  2002-02       Impact factor: 2.749

Review 3.  Diagnostic criteria and classification of mastocytosis: a consensus proposal.

Authors:  P Valent; H P Horny; L Escribano; B J Longley; C Y Li; L B Schwartz; G Marone; R Nuñez; C Akin; K Sotlar; W R Sperr; K Wolff; R D Brunning; R M Parwaresch; K F Austen; K Lennert; D D Metcalfe; J W Vardiman; J M Bennett
Journal:  Leuk Res       Date:  2001-07       Impact factor: 3.156

Review 4.  Clinical and biologic diversity of leukemias occurring in patients with mastocytosis.

Authors:  W R Sperr; H P Horny; K Lechner; P Valent
Journal:  Leuk Lymphoma       Date:  2000-05

5.  Detection of c-kit mutation Asp 816 to Val in microdissected bone marrow infiltrates in a case of systemic mastocytosis associated with chronic myelomonocytic leukaemia.

Authors:  K Sotlar; T Marafioti; H Griesser; J Theil; C Aepinus; R Jaussi; H Stein; P Valent; H P Horny
Journal:  Mol Pathol       Date:  2000-08

6.  Activating and dominant inactivating c-KIT catalytic domain mutations in distinct clinical forms of human mastocytosis.

Authors:  B J Longley; D D Metcalfe; M Tharp; X Wang; L Tyrrell; S Z Lu; D Heitjan; Y Ma
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-16       Impact factor: 11.205

Review 7.  Acute myeloid leukaemia with t(8;21) associated with "occult" mastocytosis. Report of an unusual case and review of the literature.

Authors:  H-W Bernd; K Sotlar; J Lorenzen; R Osieka; U Fabry; P Valent; H-P Horny
Journal:  J Clin Pathol       Date:  2004-03       Impact factor: 3.411

8.  Significance of systemic mast cell disease with associated hematologic disorders.

Authors:  W D Travis; C Y Li; L T Yam; E J Bergstralh; R G Swee
Journal:  Cancer       Date:  1988-09-01       Impact factor: 6.860

9.  Bone marrow mastocytosis associated with IgM kappa plasma cell myeloma.

Authors:  Florian Stellmacher; Karl Sotlar; Leopold Balleisen; Peter Valent; Hans-Peter Horny
Journal:  Leuk Lymphoma       Date:  2004-04

10.  Systemic mastocytosis with associated clonal haematological non-mast cell lineage diseases: a histopathological challenge.

Authors:  H-P Horny; K Sotlar; W R Sperr; P Valent
Journal:  J Clin Pathol       Date:  2004-06       Impact factor: 3.411

View more
  3 in total

1.  Systemic mastocytosis in association with chronic lymphocytic leukemia and plasma cell myeloma.

Authors:  Shouying Du; Hooman H Rashidi; Dzung T Le; Thomas J Kipps; H Elizabeth Broome; Huan-You Wang
Journal:  Int J Clin Exp Pathol       Date:  2010-04-23

2.  Detection of the KITD816V mutation in myelodysplastic and/or myeloproliferative neoplasms and acute myeloid leukemia with myelodysplasia-related changes predicts concurrent systemic mastocytosis.

Authors:  Jeffrey W Craig; Robert P Hasserjian; Annette S Kim; Jon C Aster; Geraldine S Pinkus; Jason L Hornick; David P Steensma; R Coleman Lindsley; Daniel J DeAngelo; Elizabeth A Morgan
Journal:  Mod Pathol       Date:  2020-01-02       Impact factor: 7.842

3.  Systemic Mastocytosis with Smoldering Multiple Myeloma: Report of a Case.

Authors:  Sassine Ghanem; Gwenalyn Garcia; Liu Ying; Matthew Hurford; Marcel Odaimi
Journal:  Case Rep Oncol Med       Date:  2016-05-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.